Details

Autor(en) / Beteiligte

• Yan, Li, MD
• Xu, Ming Tong, MD
• Yuan, Li, MD
• Chen, Bing, MD
• Xu, Zhang Rong, MD
• Guo, Qing Hua, MD
• Li, Qiang, MD
• Duan, Yu, MD
• Huang Fu, Jian, MM
• Wang, Yong Jian, MD
• Zhang, Miao, MD
• Luo, Zuo Jie, MD
• Zhao, Wei Gang, MD
• Wang, You Min, MD
• Yuan, Zhen Fang, MD
• Wang, Wei Qing, MD
• Wang, Peng Hua, MD
• Ran, Xing Wu, MD
• Wang, Yan Jun, MD
• Yang, Hua Zhang, MD
• Gao, Ling, MD
• Chen, Wei Qing, PhD
• Ning, Guang, MD, PhD

Titel

Prevalence of dyslipidemia and its control in type 2 diabetes: A multicenter study in endocrinology clinics of China

Ist Teil von

• Journal of clinical lipidology, 2016-01, Vol.10 (1), p.150-160

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2016

Quelle

MEDLINE

Beschreibungen/Notizen

• Objective The aim of this study was to assess the levels of serum lipid and awareness, treatment, and control of dyslipidemia in type 2 diabetes mellitus (T2DM) patients from top-ranked endocrinology clinics in large cities of China. Materials and Methods A cross-sectional study in a representative sample of 4807 Chinese adults 40 to 75 years of age was conducted during 2010 to 2011 at 20 endocrinology clinics in top-ranked hospitals covering most of the major cities of China. Serum lipid levels were measured, and treatment of dyslipidemia was recorded and assessed. Results In the present study, the prevalence of dyslipidemia was 67.1% in T2DM subjects. Among those with dyslipidemia, the proportion of awareness and treatment was 68.7% and 55.9%. Among participants with lipid-lowering therapy, 686 subjects achieved the low-density lipoprotein cholesterol (LDL-C) control less than 2.60 mmol/L, with the rate being 39.4%. In those patients with previous cardiovascular disease, the percentage of participants who achieved LDL-C goal (1.80 mmol/L) was 15.3%. Conclusion The prevalence of dyslipidemia is high, and the awareness, treatment, and control of dyslipidemia are relatively low in Chinese T2DM patients. This calls for the awareness and intervention of dyslipidemia in these patients.